Quanterix Corporation (QTRX): Price and Financial Metrics

Quanterix Corporation (QTRX)

Today's Latest Price: $25.16 USD

0.32 (1.29%)

Updated Dec 6 6:55pm

Add QTRX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 55 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

QTRX Stock Summary

  • QTRX's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 3 -- higher than merely 12.6% of US-listed equities with positive expected earnings growth.
  • Quanterix Corp's stock had its IPO on December 7, 2017, making it an older stock than only 4.54% of US equities in our set.
  • With a price/sales ratio of 11.1, Quanterix Corp has a higher such ratio than 90.35% of stocks in our set.
  • Stocks that are quantitatively similar to QTRX, based on their financial statements, market capitalization, and price volatility, are FLDM, AUTO, AQST, SCWX, and OBLN.
  • Visit QTRX's SEC page to see the company's official filings. To visit the company's web site, go to www.quanterix.com.
QTRX Daily Price Range
QTRX 52-Week Price Range

QTRX Stock Price Chart More Charts

QTRX Price/Volume Stats

Current price $25.16
Prev. close $24.84
Day low $24.63
Day high $25.56
50-day MA $22.36
200-day MA $25.47
52-week high $36.15
52-week low $17.08
Volume 100,100
Avg. volume 154,767
Dividend yield N/A
Market Cap 704.86M

Quanterix Corporation (QTRX) Company Bio

Quanterix Corporation develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and Asia Pacific. It develops Simoa HD-1 Analyzer, a sensitive protein detection platform, which analyzes approximately six biomarkers per test; and SR-X system that supports the detection capability of approximately six biomarkers per test. The company’s products also comprise kits, such as beads, capture and detector reagents, enzyme reagents, and enzyme substrates to run tests; and consumables, such as proprietary Simoa disks, cuvettes, and disposable tips. In addition, it offers contract research services, including sample testing, assay development, and custom development services. Quanterix Corporation primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was founded in 2007 and is based in Lexington, Massachusetts.

QTRX Latest News Stream

Event/Time News Detail
Loading, please wait...

QTRX Latest Social Stream

Loading social stream, please wait...

View Full QTRX Social Stream

QTRX Price Returns

1-mo 7.48%
3-mo 3.97%
6-mo -24.72%
1-year 29.03%
3-year N/A
5-year N/A
YTD 37.41%
2018 -14.72%
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.4986 seconds.